Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 20 January 2006:
Vol. 311. no. 5759, pp. 377 - 381
DOI: 10.1126/science.1122411
Prev | Table of Contents | Next

Reports

Vaccinia Virus-Induced Cell Motility Requires F11L-Mediated Inhibition of RhoA Signaling

Ferran Valderrama, João V. Cordeiro, Sibylle Schleich, Friedrich Frischknecht,* Michael Way{dagger}

RhoA signaling plays a critical role in many cellular processes, including cell migration. Here we show that the vaccinia F11L protein interacts directly with RhoA, inhibiting its signaling by blocking the interaction with its downstream effectors Rho-associated kinase (ROCK) and mDia. RNA interference–mediated depletion of F11L during infection resulted in an absence of vaccinia-induced cell motility and inhibition of viral morphogenesis. Disruption of the RhoA binding site in F11L, which resembles that of ROCK, led to an identical phenotype. Thus, inhibition of RhoA signaling is required for both vaccinia morphogenesis and virus-induced cell motility.

Cell Motility Laboratory, Cancer Research UK, London Research Institute, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Fields, WC2A 3PX London, UK.

* Present address: Department of Parasitology, Heidelberg University School of Medicine, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.

{dagger} To whom correspondence should be addressed. E-mail: michael.way{at}cancer.org.uk

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Epstein-Barr virus BDLF2-BMRF2 complex affects cellular morphology.
J.-B. Loesing, S. Di Fiore, K. Ritter, R. Fischer, and M. Kleines (2009)
J. Gen. Virol. 90, 1440-1449
   Abstract »    Full Text »    PDF »
Inhibition of Vaccinia Virus Replication by Two Small Interfering RNAs Targeting B1R and G7L Genes and Their Synergistic Combination with Cidofovir.
S. Vigne, S. Duraffour, G. Andrei, R. Snoeck, D. Garin, and J.-M. Crance (2009)
Antimicrob. Agents Chemother. 53, 2579-2588
   Abstract »    Full Text »    PDF »
Alphaherpesvirus US3-mediated reorganization of the actin cytoskeleton is mediated by group A p21-activated kinases.
C. Van den Broeke, M. Radu, M. Deruelle, H. Nauwynck, C. Hofmann, Z. M. Jaffer, J. Chernoff, and H. W. Favoreel (2009)
PNAS 106, 8707-8712
   Abstract »    Full Text »    PDF »
Vaccinia Virus Uses Macropinocytosis and Apoptotic Mimicry to Enter Host Cells.
J. Mercer and A. Helenius (2008)
Science 320, 531-535
   Abstract »    Full Text »    PDF »
Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines.
G. Gasteiger, W. Kastenmuller, R. Ljapoci, G. Sutter, and I. Drexler (2007)
J. Virol. 81, 11925-11936
   Abstract »    Full Text »    PDF »
Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus.
L. Jing, T. M. Chong, B. Byrd, C. L. McClurkan, J. Huang, B. T. Story, K. M. Dunkley, L. Aldaz-Carroll, R. J. Eisenberg, G. H. Cohen, et al. (2007)
J. Immunol. 178, 6374-6386
   Abstract »    Full Text »    PDF »
Helicobacter pylori CagA Induces AGS Cell Elongation through a Cell Retraction Defect That Is Independent of Cdc42, Rac1, and Arp2/3.
K. M. Bourzac, C. M. Botham, and K. Guillemin (2007)
Infect. Immun. 75, 1203-1213
   Abstract »    Full Text »    PDF »
Signaling During Pathogen Infection.
S. Munter, M. Way, and F. Frischknecht (2006)
Sci. STKE 2006, re5
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)